Related Experiment Video
Updated: Jun 20, 2026
08:34
Robot-assisted Partial Splenectomy
Published on: January 2, 2026
Splenectomy-induced long-term remission in a patient with multicentric Castleman's disease
M M E M Bos1, L M van den Berg, A W F M van Leeuwen
1Department of Internal Medicine, Reinier de Graaf Group, Delft, the Netherlands. Bos@rdgg.nl
The Netherlands Journal of Medicine
|September 22, 2009
Summary
Castleman disease, a rare disorder, has no cure. A multicentric Castleman disease patient achieved an eight-year remission after splenectomy, offering insights into potential long-term recovery mechanisms.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Castleman disease (CD) is a rare lymphoproliferative disorder with complex and incompletely understood pathogenesis.
- Multicentric Castleman disease (MCD) presents a significant clinical challenge due to its varied progression patterns and lack of curative treatment options.
Observation:
- A patient diagnosed with multicentric Castleman disease experienced a prolonged period of complete remission.
- This remission was observed for eight years following a splenectomy, without the administration of any other systemic therapies.
Findings:
- The case presents an unusual long-term complete remission in multicentric Castleman disease.
- The study explores potential underlying mechanisms that may contribute to this sustained remission post-splenectomy.
Implications:
- This case suggests that splenectomy might play a role in achieving durable remission in select MCD patients.
- Further research into the immunological and pathological mechanisms is warranted to understand this phenomenon and potentially guide future therapeutic strategies for Castleman disease.